{"title": "Masitinib-gemcitabin effect on gemcitabine-refractory Mia Paca-2 pancreatic tumor cell line", "description": "Analysis of Mia Paca2 cells after treatment with masitinib combined with standard gemcitabine chemotherapy. Masitinib is a tyrosine kinase inhibitor of c-Kit, PDGFR\u03b1 and \u03b2. Results provide insight into the therapeutic potential of masitinib in vitro on human pancreatic tumor cell lines.", "type": "Expression profiling by array", "pubmed_id": ["20209107", "22110708"], "platform": "GPL570", "platform_organism": "Homo sapiens", "platform_technology_type": "in situ oligonucleotide", "feature_count": "54675", "sample_organism": "Homo sapiens", "sample_type": "RNA", "channel_count": "1", "sample_count": "4", "value_type": "transformed count", "reference_series": "GSE17987", "order": "none", "update_date": "Jun 08 2012", "subsets": [{"dataset_id": "GDS4105", "description": "masitinib", "sample_id": ["GSM450326"], "type": "agent", "id": "GDS4105_1"}, {"dataset_id": "GDS4105", "description": "gemcitabine", "sample_id": ["GSM450327"], "type": "agent", "id": "GDS4105_2"}, {"dataset_id": "GDS4105", "description": "masitinib and gemcitabine", "sample_id": ["GSM450328"], "type": "agent", "id": "GDS4105_3"}, {"dataset_id": "GDS4105", "description": "no treatment", "sample_id": ["GSM450325"], "type": "agent", "id": "GDS4105_4"}], "taxid": "9606", "genes": 30806, "aggregation_function": "mean", "name": "GDS4105", "version": 1.0, "instances": "4", "variables": 30808, "target": "", "gene_as_attribute_name": true, "gene_id_attribute": "Entrez ID", "url": "http://file.biolab.si/geo/GDS4105.tab", "compression": "gz"}